Allergy Immunotherapy Market Size

Allergy Immunotherapy Market size was over USD 1.85 billion in 2024 and is likely to reach USD 5.81 billion by the end of 2037, witnessing around 9.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of allergy immunotherapy is assessed at USD 1.99 billion.. Because more people are developing these allergies, the market is expanding. The healthcare system is challenged by complex allergies, which cause people's health to deteriorate too much. Asthma and other allergies that affect the body's respiratory system are on the rise as a result of the environment's increasing air pollution. As per a recent report, asthma was the primary diagnosis in 38,792 hospitalizations between 2017 and 2018. Also, Asthma-related fatalities totaled 417 in 2020.

Furthermore, a rising number of immunotherapy treatments are under development to treat patients' allergies. This element is anticipated to fuel market expansion. Sublingual immunotherapy has been investigated by certain researchers for a variety of food allergies, including those to milk, peanuts, kiwis, and peaches. Numerous studies have shown that therapy cannot be effective without consistent pharmaceutical use.